We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1451
DELISTED
WW International
WW
| $426K | ﹤0.01% |
11,150
+1,050
| +10% | +$39.8K |
|
|
AVTA
1452
DELISTED
Avantax, Inc. Common Stock
AVTA
| $426K | ﹤0.01% |
16,290
-3,063
| -16% | -$68.6K |
|
1453
American States Water
AWR
$3.39B
| $425K | ﹤0.01% |
4,912
-306
| -6% | -$27.1K |
|
|
FLG
1454
Flagstar Bank National Association
FLG
$5.77B
| $424K | ﹤0.01% |
11,756
-8,210
| -41% | -$303K |
|
1455
Advance Auto Parts
AAP
$3.37B
| $423K | ﹤0.01% |
2,640
+195
| +8% | +$31.2K |
|
1456
OrthoPediatrics
KIDS
$485M
| $423K | ﹤0.01% |
9,015
+2,771
| +44% | +$107K |
|
1457
First American
FAF
$7.67B
| $422K | ﹤0.01% |
7,245
-54
| -0.7% | -$3.3K |
|
1458
Teck Resources
TECK
$29.5B
| $418K | ﹤0.01% |
24,077
-4,272
| -15% | -$69.7K |
|
|
IPG
1459
DELISTED
Interpublic Group of Companies
IPG
| $417K | ﹤0.01% |
18,062
+394
| +2% | +$8.66K |
|
1460
Invesco BuyBack Achievers ETF
PKW
$1.69B
| $417K | ﹤0.01% |
6,046
+3,191
| +112% | +$210K |
|
1461
Weis Markets
WMK
$1.82B
| $417K | ﹤0.01% |
10,295
-34,611
| -77% | -$1.34M |
|
1462
National Vision
EYE
$1.6B
| $416K | ﹤0.01% |
12,827
-150
| -1% | -$4.12K |
|
1463
NRG Energy
NRG
$29.8B
| $416K | ﹤0.01% |
10,467
-348
| -3% | -$13.8K |
|
1464
Rogers Communications
RCI
$17.7B
| $416K | ﹤0.01% |
8,391
-831
| -9% | -$40K |
|
|
HDV
1465
iShares Core High Dividend ETF
HDV
$14.4B
| $415K | ﹤0.01% |
21,175
+3,020
| +17% | +$57.6K |
|
1466
Nuveen Quality Municipal Income Fund
NAD
$2.71B
| $415K | ﹤0.01% |
28,464
-1,461
| -5% | -$21.1K |
|
1467
First Hawaiian
FHB
$3.42B
| $414K | ﹤0.01% |
14,398
-2,093
| -13% | -$58.8K |
|
|
WBK
1468
DELISTED
Westpac Banking Corporation
WBK
| $414K | ﹤0.01% |
24,421
-23,087
| -49% | -$418K |
|
1469
MPLX
MPLX
$59.5B
| $413K | ﹤0.01% |
16,249
-39,962
| -71% | -$1.02M |
|
|
PFO
1470
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$118M
| $413K | ﹤0.01% |
33,542
-575
| -2% | -$7K |
|
1471
Cullen/Frost Bankers
CFR
$10.3B
| $410K | ﹤0.01% |
4,187
-331
| -7% | -$30.8K |
|
1472
Neurocrine Biosciences
NBIX
$17.7B
| $410K | ﹤0.01% |
3,809
+685
| +22% | +$71.7K |
|
|
SRDX
1473
DELISTED
Surmodics
SRDX
| $410K | ﹤0.01% |
9,888
| – | – |
|
1474
Tapestry
TPR
$28.8B
| $410K | ﹤0.01% |
15,193
-3,082
| -17% | -$80.3K |
|
1475
Emergent Biosolutions
EBS
$375M
| $405K | ﹤0.01% |
7,520
-304
| -4% | -$16.5K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.